DOCSLIB.ORG

To Download Our Current Program Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
To Download Our Current Program Guide PSYCHEDEMIA a conference integrating psychedelics into academia PROGRAM GUIDE September 27-30, 2012 University of Pennsylvania Houston Hall 3417 Spruce Street, Philadelphia, PA i Calendar of Events Thursday (9/27) Friday (9/28) Saturday (9/29) Sunday (9/30) 9:00 - 9:30 Interdisciplinary 9:30 - 10:00 Symposium on Interdisciplinary Interdisciplinary Symposium on 10:00 - 10:30 University Symposium on Health Academics and Innovation 10:30 - 11:00 (Hall of Flags) Root Cellar 11:00 - 11:30 Research (Ben Franklin) (Bodek Lounge) (Bodek Lounge) 11:30 - 12:00 12:00 - 12:30 Lunch break 12:30 - 1:00 Lunch Break Lunch Break 1:00 - 1:30 1:30 - 2:00 : Symposium Poster Session 2:00 - 2:30 on 2:30 - 3:00 Art Theory Current 3:00 - 3:30 (Hall of Flags) Translational Interdisciplinary 3:30 - 4:00 Research on Symposium on Symposium on Individual Root Cellar 4:00 - 4:30 Psilocybin in Theory Ethics Presentations (Ben Franklin) 4:30 - 5:00 Humans (Ben Franklin) (Bodek Lounge) (Hall of Flags) (Bodek Lounge) 5:00 - 5:30 Welcome to Conference 5:30 - 6:00 (Hall of Flags) 6:00 - 6:30 Networking Reception 6:30 - 7:00 7:00 - 7:30 Closing Remarks 7:30 - 8:00 8:00 - 8:30 Special Evening Presentation 8:30 - 9:00 (Hall of Flags) 9:00 - 9:30 9:30 - 10:00 Film Screening 10:00 - 10:30 (Hall of Flags) 10:30 - 11:00 Welcome to Psychedemia! Thank you for joining us for this special event. In the past decade psychedelics have reemerged in the cultural space thanks to new research and formal exploration into psychedelic experiences.. The mission of this conference is to present this infor- mation as an academic discipline, and to foster a rational discussion about the fu- ture of psychedelics in Western culture. We hope that this conference educates, in- spires creativity, provokes critical thought, and fosters a community of curious and open minds. We encourage you to engage this conference as an active participant – to not only absorb the conversations, but to contribute to them. Ask questions during symposia. Interact with, and get to know, your fellow psychedemics. Partici- pate in all of the varied parts of the conference with equal vigor. By doing these things you will contribute to the success of a unique conference that is certain to transcend its four days. Humbly, Your Psychedemia Organizers. ♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥♥ Dedicated to the memories of John C. Lilly, Buckminster Fuller, and Terence McKenna. Lilly and Fuller were visionary scholars, both with ties to the University of Pennsylvania. Lilly, a pioneering psychonaut and researcher of consciousness using sensory deprivation tanks, dolphin communication, and psychedelics received his medical degree from the Univer- sity of Pennsylvania in 1943. Fuller, the self-proclaimed „comprehensive anticipatory design scientist‟ who invented, among many other things, the geodesic dome, taught at Penn as Pro- fessor Emeritus, appointed in 1975. Terence McKenna was a psychedelic philosopher and performance artist. The coincidence of Psychedemia with the year 2012 and the archaeology exhibit “Maya 2012:Lords of Time” at the Penn Museum would seem appropriate to him. Terence once wrote: “You are an explorer, and you represent our species, and the greatest good you can do is to bring back a new idea. Because our world is endangered by the absence of good ideas. Our world is in crisis because of the absence of consciousness.” ii Contents: i – Calendar of Events ii – Welcome iii – Contents 1 - 3 – Conference schedule 4 – Acknowledgements 5 – Explanation of access 6 – Travel information 7 – Getting to the conference 8 – Getting around the conference 9 – Conference space descriptions 10 – Program of Events (Thursday) 11 - 15 – Program of Events (Friday) 16 - 27 – Program of Events (Saturday) 28 - 30 – Program of Events (Sunday) 31 – Program of Events (Workshops) 32 - 33 – Sponsors iii Time Location What Who 9:00am - 12:00pm Hall of Flags Interdisciplinary Symposium on Psychedelics and Health F 9:00 - 9:10 Hall of Flags Introduction Conference Schedule 9:15 - 9:35 Hall of Flags ―Healing From the Gods: ayahuasca and the curing of disease states.‖ Maggi Quinlan, Ph.D. R 9:40 - 10:00 Hall of Flags ―Psychedelic Love: Sex to Transcendence.‖ Neal Goldsmith, Ph.D. ―The Effects of Psilocybin and Meditation on Personality Change in Healthy Volun- 10:05 - 10:25 Hall of Flags teers‖ Katherine MacLean, Ph.D. I 10:30 - 11:00 BREAK 11:05 - 11:25 Hall of Flags "Shamanism, right relationship, and the sacred plants" Stephan Beyer, Ph.D. D 11:30 - 12:00 Hall of Flags Panel Discussion and Q&A Panel A 12:00pm - 1:30pm Lunch Break Y 1:30pm - 3:30pm Hall of Flags Symposium on Psychedelics and Art Theory 1:30 - 1:40 Hall of Flags Introduction Ken Johnson 1:45 - 2:00 Hall of Flags "The Path and Lineage of Visionary Art: How We Opened Ourselves Up" Michael Divine 2:05 - 2:20 Hall of Flags "Principles of Artistic Vision" George Quasha : 2:25 - 2:40 Hall of Flags ―Vision Mapping for the Golden Age‖ 2:45 - 3:00 BREAK Amanda Sage 3:00 - 3:15 Hall of Flags "It Takes a Village to Raise an Art Movement" Jennifer Ingram 3:15 - 3:35 Hall of Flags Panel Discussion and Q&A Panel 3:50pm - 5:25pm Hall of Flags Individual Presentations 3:50 - 4:10 Hall of Flags ―Communicating the Unspeakable: Linguistic Phenomena in the Psychedelic Sphere‖ Diana Slattery, Ph.D. 4:15-4:35 Hall of Flags ―Emerging Psychedelics Around the World‖ Hamilton Morris 4:40 - 5:00 Hall of Flags ―Psychoactive Drugs in Western Esotericism.‖ Dan Merkur, Ph.D. 5:05 - 5:50 Hall of Flags "A Systems Approach to Describing Psychedelic States.‖ James L. Kent Psychedelic Root Cellar: The Harvard Psychedelic Club and Psychedelic Don Lattin, Stephanie 3:50pm - 5:25pm Ben Franklin Archives Schmitz, Charles Shaw 8:00pm - 9:00pm Hall of Flags Special Evening Presentation ―Clinical Perspectives in Preparing and Managing High Dose Psilocybin Sessions: Roland Griffiths, PhD, Brian 1 Insights from Johns Hopkins Spiritual Practice and Cancer Study‖ D. Richards, Psy.D, Mary Cosmano, MSW 9:00pm - 11:00pm Hall of Flags Film Screening 2 Conference Schedule Time Location What Who 9:00am - 12:00pm Bodek Lounge Interdisciplinary Symposium on University Academics and Research 9:00 - 9:10 Bodek Lounge Introduction Stephanie Schmitz S "How Does the Legal Status of Psychedelics Affect Research Opportunities and 9:15 - 9:35 Bodek Lounge Outcomes? " Jag Davies A 9:40 - 10:00 Bodek Lounge "The NYU Psilocybin Research Project" Stephen Ross, M.D. 10:05 - 10:25 Bodek Lounge "Psychedelic Studies in the Humanities" Nese L.S. Devenot, M.A. T 10:30 - 11:00 BREAK 11:05 - 11:25 Bodek Lounge "Training to Become a Psychedelic Psychotherapist" Jeffrey Guss, M.D. U 11:30 - 12:00 Bodek Lounge Panel Discussion and Q&A Panel R 10:00am - 12:00pm Ben Franklin Psychedelic Root Cellar: Myth, Poetry, and Healing Alan Bell, Charles Stein, Jonathan Talat Phillips D 12:00pm - 1:15pm Lunch Break : 1:15pm - 2:45pm Reading Room Poster Session A 2:45pm - 5:35 pm Bodek Lounge Current Translational Research on Psilocybin in Humans Y ―Overview of the Hopkins Psilocybin Research and Summary of Studies in Healthy 2:45 - 3:25 Bodek Lounge Volunteers.‖ Roland Griffiths, Ph.D. 3:25 - 4:05 Bodek Lounge ―Psilocybin Treatment of Cancer Patients.‖ William A. Richards, Ph.D. 4:05 - 4:25 BREAK 4:25 - 5:05 Bodek Lounge ―Psilocybin Treatment of Drug Dependence: smoking cessation.‖ Matthew Johnson, Ph.D. 5:05 - 5:35 Bodek Lounge Panel Discussion and Q&A Panel 3:25pm - 5:35pm Ben Franklin Symposium on Psychedelics and Theory 3:25 - 3:40 Ben Franklin "Laying a Groundwork for a Psychedelic Theory" Paul Elias 3:45 - 4:00 Ben Franklin "Measuring Immeasurable Phenomena" Drew Knight 4:00 - 4:15 Ben Franklin "Mapping the Contours of Higher Consciousness" Philip Witkin 4:20 - 4:45 BREAK ―Life, Liberty, and the Pursuit of Happiness: Why the Prohibition of Psychedelics is 4:50 - 5:05 Ben Franklin an ethical concern‖ K. Violet McKeon, M.A. 5:10 - 5:35 Ben Franklin Panel Discussion and Q&A Panel 5:30pm - 7:15pm TBD Music and Art Show and Reception Conference Schedule Time Location What Who 9:00am - 12:00pm Bodek Lounge Interdisciplinary Symposium on Psychedelics and Innovation. S 9:00 - 9:20 Bodek Lounge Introduction Introduction "Psilocybin and Mystical Experience: Implications for the treatment of existential 9:25 - 9:45 Bodek Lounge anxiety and psycho-spiritual distress in advanced cancer and end-of-life illness." Anthony Bossis, Ph.D. U "Entering the larger Conversation: : The future of interdisciplinary psychedelic stud- 9:50 - 10:10 Bodek Lounge ies." Lily Ross, MA Some Pitfalls of Psychedelic Culture: Utopian/Dystopian Delusions and Spiritual N 10:15 - 10:35 Bodek Lounge Megalomanias J.P. Harpignes 10:40 - 11:05 BREAK D 11:10 - 11:30 Bodek Lounge Ecodelics: Information Technologies for the Mind Beyond Thought Richard Doyle, Ph.D. 11:35 - 12:00 Bodek Lounge Panel Discussion and Q&A Panel A 12:00pm - 1:00pm Lunch Break Y 1:00pm - 4:00pm Bodek Lounge Interdisciplinary Symposium on Psychedelics and Ethics : 1:00 - 1:10 Bodek Lounge Introduction TBD 1:15 - 1:35 Bodek Lounge Traditional Bioethics and Possible Concerns About Self-Medication Alexander Spanos. 1:40 - 2:00 Bodek Lounge ―Why ‗ayahuasca healing‘?‖ Bia Labate/Brian Anderson 2:05 - 2:25 Bodek Lounge “Ethical considerations in the medicinal use of psychedelics―. Julie Holland, M.D. 2:30 - 2:55 BREAK ―Tim Leary and the great Harvard anesthesiologist and bioethics pioneer Henry 3:00 - 3:20 Bodek Lounge Beecher‖ Jonathan Moreno, Ph.D.
Load more

Recommended publications
  • 50. Down the Rabbit Hole with Mitch Schultz, Part 1 Recorded on 12Th August, 2019 in Byron Bay, Australia
    50. Down the Rabbit Hole with Mitch Schultz, Part 1 Recorded on 12th August, 2019 in Byron Bay, Australia. With Special Guest, Mitch Schultz. Future Sense is a podcast edited from the radio show of the same name, broadcast on BayFM in Byron Bay, Australia, at www.bayfm.org. Hosted by Nyck Jeanes and well-known international futurist, Steve McDonald, Future Sense provides a fresh, deep analysis of global trends and emerging technologies. How can we identify the layers of growth personally, socially and globally? What are the signs missed; the truths being denied? Political science, history, politics, psychology, ancient civilisations, alien contact, the new psychedelic revolution, cryptocurrency and other disruptive and distributed technologies, and much more. This is Future Sense. Nyck: You're now tuned to Future Sense with myself, Nyck Jeanes, and my co-host Steve McDonald. Good morning, Steve. Steve: Good morning, Nyck. Nyck: And it's a great pleasure to welcome back to the studio—and we just worked it out, it's been like a year and a half—our friend Mitch Schulz from the US, the Texan Elf. Mitch: Thanks for having me back, guys. Steve: Welcome back, Mitch. Nyck: It's great to have you back here. You've just arrived from Austin, Texas. Mitch: I have, and always great to be back here. I look forward to a little bit of time with you guys. Stuff's happening. 1 This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ Nyck: A bit of a sketch before we play the first track, of what we're going to be doing today.
    [Show full text]
  • Multidisciplinary Association for Psychedelic Studies
    MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES VOLUME X NUMBER 3 PSYCHEDELICS & CREATIVITY 2 m a p s • v o l u m e X n u m b e r 3 • c r e a t i v i t y 2 0 0 0 Creativity 2000 MAPS (Multidisciplinary Association for 1 Introductions Psychedelic Studies) is a membership-based Rick Doblin, Ph.D., Jon Hanna and Sylvia Thyssen organization working to assist psychedelic 4 Psychedelics and the Creation of Virtual Reality researchers around the world design, obtain Excerpted from an interview with Mark Pesce governmental approval, fund, conduct and report on psychedelic research in humans. 6 Visionary Community at Burning Man Founded in 1986, MAPS is an IRS approved By Abrupt 501 (c)(3) non-profit corporation funded 9 The Creative Process and Entheogens by tax-deductible donations. MAPS has Adapted from The Mission of Art previously funded basic scientific research By Alex Grey into the safety of MDMA (3,4-methylene- 12 Left Hand, Wide Eye dioxymethamphetamine, Ecstasy) and has By Connor Freff Cochran opened a Drug Master File for MDMA at the U.S. Food and Drug Administration. MAPS is 17 Huxley on Drugs and Creativity Excerpted from a 1960 interview for The Paris Review now focused primarily on assisting scientists to conduct human studies to generate 18 Ayahuasca and Creativity essential information about the risks and By Benny Shanon, Ph.D. psychotherapeutic benefits of MDMA, other 20 MAPS Members Share Their Experiences psychedelics, and marijuana, with the goal Anecdotes by Abram Hoffer, M.D., Ph.D., FRCP(C), of eventually gaining government Dean Chamberlain, Dan Merkur, Ph.D., Sam Patterson, approval for their medical uses.
    [Show full text]
  • ELCOCK-DISSERTATION.Pdf
    HIGH NEW YORK THE BIRTH OF A PSYCHEDELIC SUBCULTURE IN THE AMERICAN CITY A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Department of History University of Saskatchewan Saskatoon By CHRIS ELCOCK Copyright Chris Elcock, October, 2015. All rights reserved Permission to Use In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, for scholarly purposes may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make other use of material in this thesis in whole or part should be addressed to: Head of the Department of History Room 522, Arts Building 9 Campus Drive University of Saskatchewan Saskatoon, Saskatchewan S7N 5A5 Canada i ABSTRACT The consumption of LSD and similar psychedelic drugs in New York City led to a great deal of cultural innovations that formed a unique psychedelic subculture from the early 1960s onwards.
    [Show full text]
  • The Entheogen Review , Pob 19820, Sa Cramento , Ca 95819-0820, Usa  161 Vol Ume X, Number 4 Winter Solstice 2001
    VOL UME X, NUMBER 4 WINTER SOLSTICE 2001 Index Symbols Age of Entheogens & The Angels’ Dictionary, Analog Act 84, 85 The 154 Anand, Margot 67, 154 ∞Ayes 32, 49, 50, 51 age regression 89 Anderson, E.F. 106 1,4-butanediol 84 Aguaruna Indians 10 Anderson, Rocky 41 1984 155 Aguirre, G., L.E. 3, 5, 6 Anderson, Sherry 156 2001 52 Agurell, S. 57, 58, 106 Andrews, S. 86 2C-B 22, 28, 118 ahpí 7 anesthetize 21 2C-D 20 ajucá 6 angico 6 2C-I 20 Akashic record 54 angicos brancos 6 2C-T-2 20, 22, 90 Al-Queda terrorists 123 angicos pretos 6 2C-T-4 20 Alarcón, R. 5 angiquín 6 2C-T-7 20, 85, 89, 90, 94, 105, 114 Alchemind Society, The 42, 76, 112 angiquinho 6 4-acetoxy-DET 88, 89, 90, 92, 93, 96 alcohol Angraecum fragrans 86 4-acetoxy-DIPT 29, 30, 88, 90, 91, 93 38, 52, 74, 84, 98, 99, 134, 145, 146 Anon. 151 4-hydroxy-αMT 139 alcoholic beverages 86 anonymous remailer 123 4-hydroxy-DET 88, 89, 139 Aldrich 83 anthraquinones 86 4-hydroxy-DMT 88 alfalfa 129 anti-cholinergic-like central effect 150 4-hydroxy-DPT 139 alien 32, 50, 53 anti-depressant 28 5-MeO-αMT 148 alien robots 52 anti-inflammatory 86 5-MeO-DIPT 90, 94 AllChemical Arts (conference) 115 anti-marijuana laws 46 5-MeO-DMT Allen, John W. 112 anti-nausea medications 28 1, 5, 25, 84, 89, 99, 101, 102, 103, allergy preparations 28 antibacterial 135 118, 126, 148 Alli, Antero 114 antibiotic 28 5-methoxytryptamine 150 Allison 156 antidiarrheal 104 Alpert, Richard 34 antispasmatic 28 A alpha 140, 141, 142, 143, 144, 145 Antonil, André João 4 Aardvark, David α-MT 148 ants 151 α 21, 27, 28, 30, 34, 51,
    [Show full text]
  • Neuropsychedelia
    Neuropsychedelia The Revival of Hallucinogen Research since the Decade of the Brain Nicolas Langlitz UNIVERSITY OF CALIFORNIA PRESS Berkeley • Los Angeles • London Contents. University of California Press, one of the most distinguished university presses in the United States, enriches lives around the world by advancing scholarship in the humanities, social sciences, and natural sciences. Its activities are supported by the UC Press Foundation and by philanthropic contributions from individuals and institutions. For more information, visit www.ucpress.edu. University of California Press Berkeley and Los Angeles, California University of California Press, Ltd. London, England © 2013 by The Regents of the University of California Acknowledgments Vtl Library of Congress Cataloging-in-Publication Data Introduction: Neuropsychopharmacology Langlitz, Nicolas, 1975-. Neuropsychedelia : the revival of hallucinogen as Spiritual Technology I research since the decade of the brain I Nicolas Langlitz. 1. Psychedelic Revival p. cm. Includes bibliographical references and index. 2. Swiss Psilocybin and US Dollars 53 ISBN 978-0-520-27481-5 (cloth: alk. paper) ISBN 978-0-520-27482-2 (pbk. : alk. paper) 3. The Varieties of Psychedelic Lab Experience I. Hallucinogenic drugs-Research. 2. Neuropsychopharmacology. 3. Hallucinogenic 4. Enacting Experimental Psychoses 2 drugs and religious experience. 1. Title. I3 BF209·H34L36 2013 - I54·4-dc23 5. Between Animality and Divinity I66 2012022916 6. Mystic Materialism 2°4 Manufactured in the United States of America Conclusion: Fieldwork in Perennial Philosophy 243 21 20 19 18 17 16 15 14 13 10 9 8 7 6 5 4 3 2 In keeping with a commitment to support Notes environmentally responsible and sustainable printing practices, UC Press has printed this book on 50-pound Bibliography Enterprise, a 30% post-consumer-waste, recycled, Index deinked fiber that is processed chlorine-free.
    [Show full text]
  • US Censors LSD Trial, Double Life Sentence Without Parole
    FACT exposé : US censors LSD trial, double life sentence without parole The Strange Trip and Fall of Leonard Pickard Criminal Injustice in the Heartland CJ Hinke [email protected] Freedom Against Censorship Thailand (FACT) http://facthai.wordpress.com More than 13 million Americans have tried LSD. US President John F. Kennedy himself engaged in LSD sessions with his lover Mary Pinchot with acid supplied by Timothy Leary. His brother, US Attorney General Robert F. Kennedy, was a vocal critic of the LSD ban; his wife, Ethel, was successfully treated for alcoholism in LSD sessions at Vancouver’s Hollywood Hospital, under the auspices of the International Association for Psychedelic Therapy, which claimed a success rate of 80%. Both brothers were assassinated; few know that Pinchot was also assassinated in her Washington apartment in 1964; her address book was never found. This article addresses another kind of assassination, life sentences for LSD. Nike Atlas Minuteman ICBM The heartland of the United States is riddled with hundreds of nuclear missile silos, now relics of the cold war. Many of these 20+ acre properties were sold to individuals including those doomsday proponents who saw them as the perfect place for survival come Armageddon. The silos have 47-ton fortified blast doors and a 66,000-pound battery bank. They also seem to be popular as a great modern location for server farms and hacker camps. Wamego, Kansas, is the heart of the heartland and welcomed the silos for their government employment opportunities in the country’s farm belt. Waumego was named after Potawatomie chief Waumego but all the Potawatomies were killed in the American Indian Wars in frontier massacres during the mid-1800s.
    [Show full text]
  • Methoxetamine: from Drug of Abuse to Rapid-Acting Antidepressant ⇑ M
    Medical Hypotheses 79 (2012) 504–507 Contents lists available at SciVerse ScienceDirect Medical Hypotheses journal homepage: www.elsevier.com/locate/mehy Methoxetamine: From drug of abuse to rapid-acting antidepressant ⇑ M. Coppola a, , R. Mondola b a Department of Addiction, ASL CN2, Viale Coppino 46, 12051 Alba (CN), Italy b Department of Mental Health, ASL CN1, Via Torino 70/B, 12037 Saluzzo (CN), Italy article info abstract Article history: Methoxetamine is a dissociative anaesthetic showing pharmacodynamic similarities with its analogue Received 3 May 2012 ketamine, a medication with demonstrated rapid-acting antidepressant effects. Like ketamine and other Accepted 5 July 2012 arylcyclohexylamine compounds, methoxetamine is thought to be both a noncompetitive NMDA recep- tor antagonist and a dopamine reuptake inhibitor. Furthermore, it acts as an agonist at dopamine D2, serotonin 5HT2, muscarinic cholinergic, sigma-1, opioid mu and k receptors. The hypothesis is that meth- oxetamine can produce rapid antidepressant effects in patients with resistant and non-resistant unipolar and bipolar depression. Ó 2012 Elsevier Ltd. All rights reserved. Introduction N-methyl-D-aspartate (NMDA) receptors produced antidepressant effects in animal models of depression [17,18]. In recent years, Mood disorders (MD) are chronic, recurring, disabilitating psy- some clinical studies have shown that an intravenous dose of ket- chiatric illnesses that affect millions people worldwide [1,2].In amine, an N-methyl-D-aspartate (NMDA) receptor antagonist, pro- particular, major depressive disorder (MDD) is a seriously disabling duces a rapid antidepressant response within hours [19]. These public health problem that produces severe psycho-physical and studies include the treatment of resistant BD in two double-blind, socioeconomic consequences in the population [3].
    [Show full text]
  • A Full Cycle of Mental Wellness from Research to Remedy
    A Full Cycle of Mental Wellness From Research to Remedy CORPORATE PRESENTATION MAY 21, 2021 CSE:MCUR | OTC:MCURF | FRA:6MH Disclaimer & Forward Looking Statements This presentation (the “Presentation”) by MINDCURE Health Inc. (“MINDCURE”) is dated as of May 10, 2021. It is information or delivered. In this Presentation, forward-looking information includes, but is not limited to: statements pertaining to in a summary form and does not purport to be complete. It is not intended to be relied upon as advice to investors or the research, development and commercialization of technology, intellectual property or related products, or the timing potential investors and does not take into account the investment objectives, financial situation or needs of any particular thereof; the likelihood of success of any clinical trials; the likelihood of obtaining regulatory approval; the likelihood of investor. obtaining patents or the efficacy of such patents once granted; the leadership team; the potential for the markets that MINDCURE is anticipating to access; and the factors described under the caption “Risk Factors” in MINDCURE’s final INDUSTRY INFORMATION prospectus dated February 3, 2021 and documents incorporated by reference therein, and other documents publicly This Presentation does not constitute or form part of any offer for sale or solicitation of any offer to buy or subscribe filed by MINDCURE, which are available on MINDCURE’s profile at www.sedar.com for securities. This Presentation is not and under no circumstances is to be construed as a prospectus, offering memorandum, advertisement or public offering of any securities referred to herein, nor shall it or any part of it form Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and the basis of or be relied on in connection with, or act as any inducement to enter into, any contract or commitment assumptions of management at the date the statements are made, including among other things, assumptions about: whatsoever.
    [Show full text]
  • The Experiences of Kratom Users in Southern California
    THESIS CALIFORNIA ST A TE UNIVERSITY SAN MARCOS THESIS SIGNATURE PAGE THESIS SUB1\.11TTEDIN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE MASTER OF ARTS IN SOCIOLOGICAL PRACTICE TITLE: The Experiences ofKratom Users in Southern California: A Sociological Explanation AUTHOR: Claudia Lacher DATE OF SUCCESSFUL DEFENSE: April 30, 2021 THE THESIS HAS BEEN ACCEPTED BY THE THESIS COM1\.11TTEEIN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS IN SOCIOLOGICAL PRACTICE Christopher Bickel 05/07/2021 COM1\.11TTEE CHAIR SIGNATURE DATE Richelle Swan 05/07/2021 COM1\.11TTEEMEMBER SIGNATURE DATE Xuan Santos 05/07/2021 XoaIISaIItos(May 7,202113.371=e,f1 COM1\.11TTEEMEMBER SIGNATURE DATE COM1\.11TTEEMEMBER SIGNATURE DATE Table of Contents ACKNOWLEDGEMENTS ........................................................................................................... 2 ABSTRACT .................................................................................................................................. 4 INTRODUCTION ........................................................................................................................ 5 STATEMENT OF THE PROBLEM ............................................................................................. 6 LITERATURE REVIEW .............................................................................................................. 8 PHARMACOLOGY OF MITRAGYNA SPECIOSA ............................................................ 9 FROM EAST TO WEST: A Historical Tale of
    [Show full text]
  • Bath Salts Or Methylenedioxypyrovalerone (MDPV)
    New Highs for the New Millennium Brandon J. Warrick MD Assistant Clinical Professor Wayne State University Disclosures • No financial disclosures • All treatments mentioned in this talk are FDA approved. • Treatment dosing may exceed package insert Objectives • What are “Bath Salts”? • What is “Spice or K2”? • Epidemiology • Were did designer drugs come from? • Were are designer drugs going? What are “Bath Salts”? Testimonials • “I don’t believe in the hype so I ordered some offline and received in roughly a week and a half. It came in a 250mg package that ran me roughly 18 dollars with tax and shipping included. I tried roughly 10mg and absolutely loved it. Immediately after ingestion of the bath salts I felt a rush of energy and even a slight euphoria to go along with it. My mind felt like it was working in overdrive and I wanted to talk to anyone about anything I possibly could…” • “At about 1 hour and 10 minutes in I got the strongest urge to redose I have ever felt from a drug, including cocaine.” Physical Properties • White to Light Brown • Hydrophilic • Crumbly powder • Slight odor Michigan; How it Began • First call December 18, 2010 • First Death February 3 2011 • February 2-7 10 cases • Reported – Bay City – Iron Wood – Mt. Clemons PCC & Health Department Need PCC MDCH 24/7 Call Center Yes No Able to give medical advice Yes No Real-time reporting Yes Yes Able to mandate reporting No Yes Able to take legal action No Yes Able to create EPI-X alerts* Yes Yes Able to create HAN* No Yes Able to submit MMWR* No Yes Participates in
    [Show full text]
  • 4 the Psychedelic Landscape
    University of Plymouth PEARL https://pearl.plymouth.ac.uk 04 University of Plymouth Research Theses 01 Research Theses Main Collection 2011 Communicating the Unspeakable: Linguistic Phenomena in the Psychedelic Sphere Slattery, Diana R. http://hdl.handle.net/10026.1/549 University of Plymouth All content in PEARL is protected by copyright law. Author manuscripts are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author. 3 Author's Declaration At no time during the registration for the degree of Doctor of Philosophy has the author been registered for any other University award without prior agreement of the Graduate Committee. This study was self-financed. Relevant scientific seminars and conferences were regularly attended at which work was often presented; several papers were prepared for publication. These are listed in Appendix IV. Word count of main body of thesis: 87, 322. Signed l'>^!:f:ffif:?:^...^.! Date ..Zl..d^^$:^..^.±LL COMMUNICATING THE UNSPEAKABLE: LINGUISTIC PHENOMENA IN THE PSYCHEDELIC SPHERE by DIANA REED SLATTERY A thesis submitted to the University of Plymouth in partial fulfillment for the degree of DOCTOR OF PHILOSOPHY Planetary Collegium Faculty of Arts AUGUST 2010 Copyright Statement This copy of the thesis has been supplied on Condition that any one who consults it is understood to recognize that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without the author's prior consent.
    [Show full text]
  • Corporate Presentation, April 2021
    Corporate Presentation, April 2021 CSE:MCUR | OTC:MCURF | FRA:6MH Disclaimer This presentation (the “Presentation”) by MINDCURE Health Inc. (“MINDCURE”) is dated as of February, 2021. It is information in a summary form and does not purport to be complete. It is not intended to be relied upon as advice to investors or potential investors and does not take into account the investment objectives, financial situation or needs of any particular investor. INDUSTRY INFORMATION This Presentation does not constitute or form part of any offer for sale or solicitation of any offer to buy or subscribe for securities. This Presentation is not and under no circumstances is to be construed as prospectus, offering memorandum, advertisement or public offering of any securities referred to herein, nor shall it or any part of it form the basis of or be relied on in connection with, or act as any inducement to enter into, any contract or commitment whatsoever. Recipients of this Presentation who are considering acquiring securities of MINDCURE are referred to the entire body of publicly disclosed information regarding MINDCURE. The information is subject to material updating, revision and further amendment, and is qualified entirely by reference to MINDCURE’s publicly disclosed information. This Presentation includes market and industry data and forecasts that have been obtained from third party sources, including industry publications. MINDCURE believes that the industry data and forecasts are generally reliable and that the estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information.
    [Show full text]